Tradestie Institutional Equity Comparison Engine

MPLT vs ALMS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MPLT Overall Edge

MPLT Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MapLight Therapeutics, Inc. (MPLT) driven by superior Growth & Margin, Momentum & Technical while ALMS counters with relative strength in Options & Structure. Fundamentally, MPLT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ALMS at N/M Forward P/E and -5744.5% operating margin (-37.7% YoY). In options structure, MPLT sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against ALMS sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MPLT N/M vs ALMS N/M Fwd P/E
Growth & Margin Winner MPLT
Op Margin 0.0% vs -5744.5% ยท YoY +0.0% vs -37.7%
Momentum & Technical Winner MPLT
1Y -51.4% vs -4.2% ยท 52W Pos 3% vs 2%
Options & Structure Winner ALMS
BREAKDOWN (8th %ile IV) vs BREAKDOWN (8th %ile IV)
MPLT US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$6.94
-4.28% 1D
Market Cap $392.9M
1M Return -9.87%
1Y Return -51.4%
Forward P/E N/M
Unified AI Score
50.4 / 100 HOLD
Tech 49.0 Fund 56.0 Flow 64.0 Mom 58.9
ALMS NASDAQ
Alumis Inc. Common Stock
Pharmaceutical Preparations
$5.06
-9.65% 1D
Market Cap $793.4M
1M Return -17.33%
1Y Return -4.18%
Forward P/E N/M
Unified AI Score
43.3 / 100 HOLD
Tech 20.0 Fund 51.0 Flow 67.0 Mom 74.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MPLT -51.4% ALMS -4.18% Spread: +47.22 pp (ALMS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MPLT TTM Op. Margin: 0.0% ALMS TTM Op. Margin: -5744.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPLT vs ALMS. Trailing 12-month operating profitability (MPLT 0.0% vs ALMS -5744.5%) and valuation multiples (MPLT N/M vs ALMS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MPLT (5) vs ALMS (2)
Institutional Metric MPLT ALMS Criterion Row Winner
Market Capitalization Scale $392.9M $793.4M Larger Scale ALMS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -37.7% Higher Growth MPLT
Operating Margin (TTM) Profitability 0.0% -5744.5% Higher Margin MPLT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -111.5% -93.7% Higher ROE ALMS
52-Week Range Position Momentum 3% ($6โ€“$40) 2% ($5โ€“$31) Stronger Trend MPLT
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 78% Vol 2.24ฮฒ ยท 86% Vol Lower Realized Risk MPLT
Unified Institutional Score Composite Signal 50.4 / 100 (HOLD) 43.3 / 100 (HOLD) Higher Composite MPLT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MPLT vs ALMS Buy Guide
MPLT BREAKDOWN
144d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live MPLT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ALMS BREAKDOWN
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ALMS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MPLT nor ALMS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.